Literature DB >> 16867806

A comparison of plasma levels of hyoscine after oral and transdermal administration.

C Muir1, R Metcalfe.   

Abstract

Entities:  

Year:  1983        PMID： 16867806     DOI： 10.1016/0731-7085(83)80048-x

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN： 0731-7085            Impact factor:   3.935


× No keyword cloud information.
  9 in total

Review 1.  Risks and benefits of drugs used in the management of postoperative nausea and vomiting.

Authors:  Y F Sung
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

Review 2.  Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.

Authors:  Zohar Nachum; Avi Shupak; Carlos R Gordon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

Review 4.  [Recommendations for death rattle].

Authors:  T Pastrana; H Reineke-Bracke; F Elsner
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

5.  Pharmacokinetics and oral bioavailability of scopolamine in normal subjects.

Authors:  L Putcha; N M Cintrón; J Tsui; J M Vanderploeg; W G Kramer
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

Review 6.  Pharmacokinetic considerations in the use of newer transdermal formulations.

Authors:  G Ridout; G C Santus; R H Guy
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

7.  Transdermally applied scopolamine does not impair psychomotor performance.

Authors:  C H Gleiter; K H Antonin; P R Bieck
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 8.  Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; R C Heel
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

9.  Scopolamine Reduces Electrophysiological Indices of Distractor Suppression: Evidence from a Contingent Capture Task.

Authors:  Inga Laube; Natasha Matthews; Angela J Dean; Redmond G O'Connell; Jason B Mattingley; Mark A Bellgrove
Journal:  Front Neural Circuits       Date:  2017-12-06       Impact factor: 3.492
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.